Hold. The supplied data show a mild but persistent decline over one, two, and four weeks, but not a decisive breakdown: the 7-day, 14-day, and 30-day changes are -1.47%, -2.27%, and -3.33%, respectively. Against that weakness, the current price of $1.14 is at the reported 24-hour high, and the day’s range is narrow at $1.13–$1.14.

The trend over those three periods is consistently negative, with the loss increasing as the measurement window lengthens. This is the clearest bearish signal in the data, though the reported declines are limited in size and do not establish that the downward move is accelerating in the most recent 24 hours.

The moving-average readings are mixed rather than uniformly bearish. The 8-, 13-, and 21-period readings show positive changes of +0.45%, +0.25%, and +0.09%, while the 55- and 144-period readings are negative at -0.05% and -0.31%; this favors short-term improvement but leaves the longer readings on the weak side.

Momentum readings also do not indicate a strong directional extreme. The 1-hour RSI is 46 and the 7-day RSI is 44, both below 50 but not so low that the supplied figures alone indicate an oversold condition; they are consistent with modest weakness rather than a pronounced momentum signal.

Reported 24-hour volume is zero, with volume-to-market-cap also at 0.00%. That removes an important source of confirmation: the price changes and moving-average signals cannot be assessed against recorded trading activity from the supplied data.

At $1.14, the price is about 3.4% below the $1.18 all-time high. The high is a reference point in the data, not evidence by itself that price will return to it; the multiweek declines argue against treating proximity to that high as a bullish signal.

The negative 24-hour change of 0.50% conflicts with the fact that the current quote equals the reported 24-hour high. This indicates that the daily endpoint is comparatively strong within its stated range, but it does not erase the longer-window declines or establish a sustained reversal.

Overall, Hold best reflects the balance of evidence: multiweek performance is negative, while the narrow daily range, current price at the day’s high, and positive short-period moving-average readings provide some counterweight. The primary reasons not to rate Buy are the consistent 7-, 14-, and 30-day losses and zero reported volume; the primary reasons not to rate Sell are the modest size of those losses and mixed-to-improving short-term readings.